Filing Details

Accession Number:
0000059478-18-000161
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2018-06-01 16:16:41
Reporting Period:
2018-05-29
Accepted Time:
2018-06-01 16:16:41
Original Submission Date:
2018-05-31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1702473 Christi Shaw Lilly Corporate Center
Indianapolis IN 46285
Svp And Pres., Lilly Bio-Meds No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-05-29 8,426 $82.10 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This amendment is being filed to add footnotes to the transaction.
  2. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 26, 2018.
  3. This transaction was executed in multiple trades at prices ranging from $81.73 to $82.10. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.